You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

CLINICAL TRIALS PROFILE FOR GABLOFEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for GABLOFEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01520545 ↗ Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump Completed Mallinckrodt Phase 3 2012-12-01 Safety study to assess the 3 mg/mL baclofen injection (intrathecal) using a programmable pump
NCT01520545 ↗ Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump Completed Piramal Critical Care, Ltd. Phase 3 2012-12-01 Safety study to assess the 3 mg/mL baclofen injection (intrathecal) using a programmable pump
NCT01821560 ↗ Baclofen Effects in Cigarette Smokers Completed National Institute on Drug Abuse (NIDA) Phase 2 2013-03-01 The proposed project will utilize perfusion functional magnetic resonance imaging (fMRI), a functional candidate gene association approach (of dopaminergic addictions-targeted polymorphisms), and the dopamine-modulating and gamma-aminobutyric acid (GABA) B receptor agonist, baclofen, to examine the brain and behavioral responses in smokers to appetitive smoking reminders (cues that motivate continued smoking and relapse). These studies will provide a means to identify an appetitive cue-sensitive pharmacologic-responsive endophenotype. Once brain/behavioral/genetic endophenotypes can be determined prior to treatment, smoking cessation treatments can be structured to meet individual needs, which will significantly improve treatment outcome.
NCT01821560 ↗ Baclofen Effects in Cigarette Smokers Completed National Institutes of Health (NIH) Phase 2 2013-03-01 The proposed project will utilize perfusion functional magnetic resonance imaging (fMRI), a functional candidate gene association approach (of dopaminergic addictions-targeted polymorphisms), and the dopamine-modulating and gamma-aminobutyric acid (GABA) B receptor agonist, baclofen, to examine the brain and behavioral responses in smokers to appetitive smoking reminders (cues that motivate continued smoking and relapse). These studies will provide a means to identify an appetitive cue-sensitive pharmacologic-responsive endophenotype. Once brain/behavioral/genetic endophenotypes can be determined prior to treatment, smoking cessation treatments can be structured to meet individual needs, which will significantly improve treatment outcome.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for GABLOFEN

Condition Name

Condition Name for GABLOFEN
Intervention Trials
Liver Cirrhosis 1
Marijuana Dependence 1
Muscle Cramps 1
Nicotine Dependence 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for GABLOFEN
Intervention Trials
Fibrosis 1
Marijuana Abuse 1
Tobacco Use Disorder 1
Muscle Spasticity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for GABLOFEN

Trials by Country

Trials by Country for GABLOFEN
Location Trials
United States 13
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for GABLOFEN
Location Trials
Pennsylvania 2
Wisconsin 1
Utah 1
Texas 1
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for GABLOFEN

Clinical Trial Phase

Clinical Trial Phase for GABLOFEN
Clinical Trial Phase Trials
Phase 3 1
Phase 2 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for GABLOFEN
Clinical Trial Phase Trials
Completed 3
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GABLOFEN

Sponsor Name

Sponsor Name for GABLOFEN
Sponsor Trials
University of Pennsylvania 2
Tanta University 1
Mallinckrodt 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for GABLOFEN
Sponsor Trials
Other 4
Industry 2
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.